RecruitingNCT05248581
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
Liver Transplantation From Living Donors For Treatment Of Non-Resectable Colorectal Carcinoma Liver Metastases: A Registry Study
Sponsor
University of Rochester
Enrollment
25 participants
Start Date
Aug 16, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age ≥ 18
- Non-amenable to curative hepatic resection as defined by FLR <30%
- Histologically confirmed adenocarcinoma of the colon or rectum
- Candidate for LDLT for colorectal liver metastasis per the University of Rochester liver transplant program
Exclusion Criteria2
- Not a candidate of the LDLT liver transplant protocol for treatment of colorectal liver metastasis.
- Unwilling to consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURELiver transplantation
living donor liver transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05248581
Related Trials
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
NCT066348752 locations
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
NCT063004631 location
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
NCT071722821 location
Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
NCT074626501 location
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
NCT071938622 locations